RecruitingNot Applicable

An International Study on Pediatric Patients With Rare Tumors.

Italy6,250 participantsStarted 2025-01-25

Plain-language summary

The PARTNER study is an international, prospective, observational study of paediatric patients with very rare tumours.

Who can participate

Age range0 Years – 18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Children and adolescents (age 0-18 years) with a primary or relapsed Very Rare Tumor diagnosed and/or treated in a participating country/center. * Written informed consent from the patient and/or the parent/legal guardian Exclusion Criteria: * Absence of Written informed consent from the patient and/or the parent/legal guardian

What they're measuring

Epidemiology

Timeframe: through study completion, an average of 1 year

Use of International Recommendations

Timeframe: through study completion, an average of 1 year

Survival of children and adolescents (0-18 years) affected by Very Rare Tumors

Timeframe: through study completion, an average of 1 year

Trial details

NCT IDNCT07072143

SponsorAzienda Ospedaliera di Padova

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2049-01-06

Contact for this trial

Gianni Bisogno, MD

0039 0498211481 gianni.bisogno@unipd.it

View on ClinicalTrials.gov More Paraganglioma/ Phaeochromocytoma trials